Overview

Augmenting Flortaucipir Dosimetry Estimates

Status:
Completed

Trial end date:
2015-06-01

Target enrollment:

Participant gender:

Summary

This study will obtain data from urine in subjects administered flortaucipir in an Avid-sponsored study to augment the calculation of radiation dosimetry estimates.

Phase:

Phase 1

Details

Lead Sponsor:

Avid Radiopharmaceuticals